Matches in Wikidata for { <http://www.wikidata.org/entity/Q28373805> ?p ?o ?g. }
- Q28373805 description "2000 nî lūn-bûn" @default.
- Q28373805 description "2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q28373805 description "2000 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q28373805 description "2000年の論文" @default.
- Q28373805 description "2000年論文" @default.
- Q28373805 description "2000年論文" @default.
- Q28373805 description "2000年論文" @default.
- Q28373805 description "2000年論文" @default.
- Q28373805 description "2000年論文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000年论文" @default.
- Q28373805 description "2000년 논문" @default.
- Q28373805 description "article científic" @default.
- Q28373805 description "article scientific" @default.
- Q28373805 description "article scientifique (publié 2000)" @default.
- Q28373805 description "articol științific" @default.
- Q28373805 description "articolo scientifico" @default.
- Q28373805 description "artigo científico (publicado na 2000)" @default.
- Q28373805 description "artigo científico (publicado na 2000)" @default.
- Q28373805 description "artigo científico" @default.
- Q28373805 description "artikull shkencor" @default.
- Q28373805 description "artikulong pang-agham" @default.
- Q28373805 description "artykuł naukowy" @default.
- Q28373805 description "artículo científico publicado en 2000" @default.
- Q28373805 description "artículu científicu espublizáu en 2000" @default.
- Q28373805 description "bilimsel makale" @default.
- Q28373805 description "bài báo khoa học" @default.
- Q28373805 description "im April 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q28373805 description "mokslinis straipsnis" @default.
- Q28373805 description "naučni članak" @default.
- Q28373805 description "scienca artikolo" @default.
- Q28373805 description "scientific article" @default.
- Q28373805 description "teaduslik artikkel" @default.
- Q28373805 description "tieteellinen artikkeli" @default.
- Q28373805 description "tudományos cikk" @default.
- Q28373805 description "vedecký článok (publikovaný 2000-04)" @default.
- Q28373805 description "vetenskaplig artikel" @default.
- Q28373805 description "videnskabelig artikel (udgivet 2000)" @default.
- Q28373805 description "vitenskapelig artikkel" @default.
- Q28373805 description "vitskapeleg artikkel" @default.
- Q28373805 description "vědecký článek publikovaný v roce 2000" @default.
- Q28373805 description "wetenschappelijk artikel (gepubliceerd in 2000-04)" @default.
- Q28373805 description "wüsseschaftlicher Artikel, wo im April 2000 veröffentlicht worden isch" @default.
- Q28373805 description "επιστημονικό άρθρο" @default.
- Q28373805 description "мақолаи илмӣ" @default.
- Q28373805 description "мақолаи илмӣ" @default.
- Q28373805 description "наукова стаття, опублікована у квітні 2000" @default.
- Q28373805 description "научна статия" @default.
- Q28373805 description "научная статья" @default.
- Q28373805 description "научни чланак" @default.
- Q28373805 description "научни чланак" @default.
- Q28373805 description "מאמר מדעי" @default.
- Q28373805 description "سائنسی مضمون" @default.
- Q28373805 description "مقالة علمية (نشرت في أبريل 2000)" @default.
- Q28373805 description "مقالهٔ علمی" @default.
- Q28373805 description "২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q28373805 description "บทความทางวิทยาศาสตร์" @default.
- Q28373805 description "სამეცნიერო სტატია" @default.
- Q28373805 name "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 name "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 name "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 type Item @default.
- Q28373805 label "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 label "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 label "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 prefLabel "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 prefLabel "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 prefLabel "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 P1433 Q28373805-3FCAB5C3-8CD6-4338-9D40-64611F41FC99 @default.
- Q28373805 P1476 Q28373805-1731F21D-3582-4485-8008-20E54E998A4D @default.
- Q28373805 P2093 Q28373805-0CAF7AF1-CD4E-483A-8E2E-EE1116B3C5EF @default.
- Q28373805 P2093 Q28373805-2AB13779-9395-4BB1-A31D-4550D6A2AB44 @default.
- Q28373805 P2093 Q28373805-2D5E6D85-46B8-4441-8094-31186312346D @default.
- Q28373805 P2093 Q28373805-5E015B44-C8F0-4131-BD56-29776AAA44FD @default.
- Q28373805 P2093 Q28373805-672F4306-9FAB-48D1-BE2D-D3AD730041A8 @default.
- Q28373805 P2093 Q28373805-6A3EDFBC-A4E4-46E4-8A1F-4124D03C3C34 @default.
- Q28373805 P2093 Q28373805-CA34BBCE-190F-4005-81C0-A8CADD9CE11C @default.
- Q28373805 P2093 Q28373805-D5B1F3D1-622D-46DD-BAE4-935459D4715E @default.
- Q28373805 P304 Q28373805-D1851CE9-F12C-485D-99F8-2685050307C2 @default.
- Q28373805 P31 Q28373805-CCB68616-2EC5-4D76-A7FB-85F8CC925FAE @default.
- Q28373805 P356 Q28373805-178E409D-2DBE-429A-9C4B-E68B9F8D4D1B @default.
- Q28373805 P407 Q28373805-6D97ADB0-74CF-4103-AFA6-333078228F3F @default.
- Q28373805 P433 Q28373805-A8145F2A-1032-4D29-A314-F21002E692BD @default.
- Q28373805 P478 Q28373805-F4F02ED4-8786-458D-BEE1-22EA0AB8DD2E @default.
- Q28373805 P577 Q28373805-922BA811-9D57-47C0-90D4-C97A22C0371F @default.
- Q28373805 P698 Q28373805-CC9E36AA-4C19-4D6F-83BD-F28EC29BFCA1 @default.
- Q28373805 P921 Q28373805-18568255-71E2-4736-B259-A27C533C5A16 @default.
- Q28373805 P921 Q28373805-F54A5BF8-F015-4E56-A68A-9501DE53CEA1 @default.
- Q28373805 P356 15.4.487 @default.
- Q28373805 P698 10727543 @default.
- Q28373805 P1433 Q15710302 @default.
- Q28373805 P1476 "The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group" @default.
- Q28373805 P2093 "D A Anzalone" @default.
- Q28373805 P2093 "E J Lewis" @default.
- Q28373805 P2093 "E Ritz" @default.
- Q28373805 P2093 "L G Hunsicker" @default.